About this resource:

HHS Non-systematic Review

Source: Institute of Medicine

Last Reviewed: 2004

Workgroups: Immunization and Infectious Diseases Workgroup

This report presents the results from an evaluation of vaccine purchase financing in the United States. The report describes current and future challenges for the national immunization system. It also outlines the Institute of Medicine’s findings, conclusions, and recommendations for achieving national immunization goals. Specifically, the report provides evidence-based strategies to help federal, state, and congressional decision-makers ensure that vaccines are accessible and available and to encourage new vaccine development in the health care system.

Read more about this resource

Objectives related to this resource (6)

Increase the coverage level of 4 doses of the DTaP vaccine in children by age 2 years — IID‑06
Little or no detectable change
Maintain the vaccination coverage level of 1 dose of the MMR vaccine in children by age 2 years — IID‑03
Little or no detectable change
Reduce the proportion of children who get no recommended vaccines by age 2 years — IID‑02
Target met or exceeded
Increase the proportion of adolescents who get recommended doses of the HPV vaccine — IID‑08
Improving
Increase the proportion of people who get the flu vaccine every year — IID‑09
Baseline only
Maintain the vaccination coverage level of 2 doses of the MMR vaccine for children in kindergarten — IID‑04
Target met or exceeded

Suggested Citation

1.

Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. https://doi.org/10.17226/10782.